Barcelos Pedro Marçal, Filgueiras Igor Salerno, Nóbile Adriel Leal, Usuda Júlia Nakanishi, Adri Anny Silva, de Alburquerque Débora Gomes, Côrrea Yohan Lucas Gonçalves, do Vale Fernando Yuri Nery, Bahia Ian Antunes Ferreira, Nava Roseane Galdioli, Boroni Mariana, Marques Alexandre H C, Dalmolin Rodrigo, Schimke Lena F, Cabral-Miranda Gustavo, Nakaya Helder I, Dias Haroldo Dutra, Fonseca Dennyson Leandro M, Cabral-Marques Otavio
Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo (USP), Av. Prof. Lineu Prestes, 580, São Paulo, SP, 05508-000, Brazil.
Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil.
Sci Rep. 2025 Apr 23;15(1):14034. doi: 10.1038/s41598-025-98542-7.
Gliomas are the most common and aggressive primary tumors of the central nervous system. Dysregulated transcription factors (TFs) and genes have been implicated in glioma progression, yet these tumors' overall structure of gene regulatory networks (GRNs) remains undefined. We analyzed transcriptional data from 989 primary gliomas in The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) to address this. GRNs were reconstructed using the RTN package which identifies regulons-sets of genes regulated by a common TF based on co-expression and mutual information. Regulon activity was evaluated through Gene Set Enrichment Analysis. Elastic net regularization and Cox regression identified 31 and 32 prognostic genes in the TCGA and CGGA datasets, respectively, with 11 genes overlapping, many of which are associated with neural development and synaptic processes. GAS2L3, HOXD13, and OTP demonstrated the strongest correlations with survival outcomes among these. Single-cell RNA-seq analysis of 201,986 cells revealed distinct expression patterns for these genes in glioma subpopulations, particularly oligoprogenitor cells. This study uncovers key GRNs and prognostic genes in gliomas, offering new insights into tumor biology and potential therapeutic targets.
神经胶质瘤是中枢神经系统最常见且侵袭性最强的原发性肿瘤。转录因子(TFs)和基因失调与神经胶质瘤的进展有关,但这些肿瘤的基因调控网络(GRNs)的整体结构仍不明确。为了解决这个问题,我们分析了来自癌症基因组图谱(TCGA)和中国神经胶质瘤基因组图谱(CGGA)的989例原发性神经胶质瘤的转录数据。使用RTN软件包重建基因调控网络,该软件包基于共表达和互信息识别由共同转录因子调控的基因集(即调控子)。通过基因集富集分析评估调控子活性。弹性网络正则化和Cox回归分别在TCGA和CGGA数据集中鉴定出31个和32个预后基因,其中有11个基因重叠,其中许多基因与神经发育和突触过程相关。在这些基因中,GAS2L3、HOXD13和OTP与生存结果的相关性最强。对201,986个细胞进行的单细胞RNA测序分析揭示了这些基因在神经胶质瘤亚群,特别是少突胶质前体细胞中的不同表达模式。这项研究揭示了神经胶质瘤中的关键基因调控网络和预后基因,为肿瘤生物学和潜在治疗靶点提供了新的见解。